The plain answer
For almost every patient sent to a UK cardiologist in 2026, the first heart scan is an echocardiogram, not a cardiac MRI. Echo is quick, portable, radiation free, and it answers most of the questions that come up in a first consultation. Cardiac MRI is added when echo cannot see clearly enough, or when the clinical question needs tissue characterisation that ultrasound simply cannot do.
So the honest hierarchy is this. Echo first for screening, valve disease, ejection fraction and pericardial disease. Cardiac MRI when the echo picture is limited, when the differential includes myocarditis or a cardiomyopathy, when a suspected scar needs to be mapped, or when a congenital abnormality or cardiac mass has been flagged. The two tests are complementary, not competitors. This piece walks through exactly when your cardiologist reaches for each one, and why.
What an echocardiogram actually measures
An echocardiogram is a real-time ultrasound of the heart. The sonographer puts a probe on your chest, and the ultrasound beam builds a two-dimensional moving picture of the chambers, the valves and the sac around the heart. Doppler is layered on top to show the direction and velocity of blood flow, which is how valve leaks, valve narrowings and pressure gradients are measured.
In a standard transthoracic echo (the kind done in an outpatient clinic) the cardiologist gets a reliable estimate of left ventricular ejection fraction, chamber sizes, wall thickness, regional wall motion, all four valves, pulmonary artery pressure, and pericardial fluid. That covers the majority of first-line cardiology questions - suspected heart failure, breathlessness, murmurs, high blood pressure follow-up, palpitations with a family history, pre-operative assessment, and monitoring of known valve disease.
When the transthoracic view is limited - large body habitus, lung disease in the way, prosthetic valves, suspected endocarditis, or a cardiac source of stroke - a transoesophageal echo (TOE) is done under sedation with the probe passed into the oesophagus, which sits directly behind the heart. TOE gives beautiful high-resolution views but it is semi-invasive.
What cardiac MRI adds
Cardiac MRI does everything echo does, and then does five things echo cannot. It measures ventricular volumes and ejection fraction in three dimensions with the highest accuracy available in medicine - which is why cardiac MRI is the reference standard for clinical trials. It quantifies valve regurgitation with phase-contrast flow imaging. It maps myocardial scar, inflammation, oedema, iron overload and infiltration through tissue characterisation sequences. It shows perfusion under stress. And it gives unrivalled anatomical detail for congenital heart disease and cardiac masses.
Late gadolinium enhancement (LGE) is the single most important thing a cardiac MRI does that an echo cannot. A small dose of gadolinium contrast is given intravenously; ten minutes later, healthy myocardium washes the contrast out, but scar and fibrosis hold on to it and light up on the images. The pattern of that scar (subendocardial, mid-wall, subepicardial, patchy, diffuse) tells the cardiologist which disease process is likely - a previous heart attack, myocarditis, hypertrophic cardiomyopathy, sarcoid, amyloid, and so on.
The five clinical questions where MRI wins
These are the situations where a UK cardiologist will almost always add a cardiac MRI, even after a normal or borderline echo:
- Suspected myocarditis. Chest pain with a raised troponin and unobstructed coronary arteries is the classic setup. Echo may look normal. Cardiac MRI shows the oedema, the LGE pattern and the recovery timeline, and it is the diagnostic reference standard for myocarditis in 2026.
- Cardiomyopathy characterisation. Echo can tell you the ventricle is thickened, dilated or hypokinetic. Only MRI can tell you the disease behind it - hypertrophic, dilated, arrhythmogenic, sarcoid, amyloid, iron overload, Fabry - because each one has a distinct scar and tissue-mapping signature.
- Viability after a heart attack. After a large MI, the question before revascularisation is whether the affected muscle is still alive. LGE quantifies scar transmurality and predicts recovery after revascularisation more reliably than any other test.
- Congenital heart disease in adults. Complex anatomy, right ventricular function, shunt quantification and post-surgical follow-up are all done far better on MRI than on echo, particularly in adults where the acoustic windows are limited.
- Cardiac masses. If echo sees "something" in a chamber - a suspected thrombus, tumour or vegetation - cardiac MRI characterises it (fatty, cystic, vascular, infiltrative) with a level of confidence echo cannot reach.
The five clinical questions where echo is enough
Equally important - these are the situations where an MRI adds little on top of a good echo, and the NHS or private cardiologist will almost always stop at echo:
- Screening for reduced ejection fraction. New breathlessness or ankle swelling in a primary-care pathway is investigated first with echo. If EF is normal and the valves are normal, MRI usually does not change management.
- Routine follow-up after an uncomplicated MI. If revascularisation went well and function is preserved on echo, MRI is not needed at every visit.
- Heart failure surveillance. Once the diagnosis is made and treatment is titrated, serial echoes are the norm for tracking ejection fraction and remodelling.
- Valve disease assessment and follow-up. Almost all valve stenosis and regurgitation is graded, staged and followed with echo. TOE is added for surgical planning or suspected endocarditis. MRI is used only when echo is inconclusive.
- Pericardial effusion. Echo is the fastest and most sensitive way to detect fluid around the heart and to guide drainage if needed.
